Published by Michele Maatouk on 8th May 2025
(Sharecast News) - Hikma Pharmaceuticals said on Thursday that it has entered into a preliminary $50m class settlement agreement that resolves the majority of its Xyrem (sodium oxybate) antitrust class action cases in the US.
URL: http://www.digitallook.com/dl/news/story/35066010/...